RYTM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Rhythm Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 90.64 USD 3.93% Market Closed

Market Cap: $6.2B

	Rhythm Pharmaceuticals Inc NASDAQ:RYTM	US

Profitability Summary

Rhythm Pharmaceuticals Inc's profitability score is 19/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

89%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

90% > 89%

Negative Operating Margin

-91%

Negative 3Y Average Operating Margin

-222%

Operating Margin is Increasing

-533% > -91%

Negative Net Margin

-96%

Negative 3Y Average Net Margin

-224%

Net Margin is Increasing

-537% > -96%

Negative Free Cash Flow Margin

-55%

Negative 3Y Average Free Cash Flow Margin

-126%

Free Cash Flow Margin is Increasing

-465% > -55%

Negative ROE

-104%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-459%

ROIC is Increasing

-514% > -265%

View All

Hide

Collapse

19 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.